13/NTB/116 Approve Redesigning Daily Occupations Dr Kirk Reed Kate O'Connor Intervention 3D Imaging of Neonatal And Paediatric 13/NTB/120 Approve Dr Michael Meyer Dr Samantha Everitt (CMDHB) Observational Subjects Canterbury Urology Research 178-CL-101.To find out in patients with Points Research overactive bladder (OAB) if combinations of Ltd,John Tuckey,michael 13/NTB/123 Approve two drugs (Solifenacin Succinate and Mr Stephen Mark Intervention holmes,Patrick James Mirabegron) are safe, well tolerated and Meffan,Tauranga Urology have efficacy, compared to placebo and Research Ltd Clinical A/Prof John 13/NTB/124 Approve Type 2 diabetes in dialysis patients Dr Jasmine Tan Collins,Professor Tim Auckland District Health Board Observational Cundy MDMA 13/NTB/125 Approve Dr Grant Searchfield Intervention and tinnitus 13/NTB/126 Approve OPTIMIST A Prof Peter Dargaville Dr Mariam Buksh Intervention Associate Professor 13/NTB/128 Decline Metacognitive Therapy for Anorexia Nervosa Intervention Janet Carter An investigation into the tolerability of 13/NTB/129 Approve Dr Chepulis Intervention Manuka CyclopowerTM chewable tablets Evaluation of TAF vs TDF in patients with Auckland Clinical Studies 13/NTB/130 Approve Prof Edward Gane Intervention HBeAg positive Chronic HBV Limited,Christopher Trial Moyes Auckland Clinical Studies Evaluation of TAF vs TDF in patients with 13/NTB/131 Approve Prof Edward Gane Limited,Christopher David Intervention negative Chronic HBV Moyes Effectiveness and Safety of FG-4592 for the Dr Kannaiyan Dr Samantha Everitt 13/NTB/143 Approve treatment of anaemia in people with CKD not Dr David M. Voss Intervention Rabindranath (CMDHB),Jan Adams, COO on dialysis Provisionally 13/NTB/144 Aspiration therapy for treating obesity Dr Dinesh Lal Intervention approve
13/NTB/116 Approve Redesigning Daily Occupations Dr Kirk Reed Kate O'Connor Intervention 13/NTB/120 Approve 3D Imaging of Neonatal And Paediatric Subjects Dr Michael Meyer Dr Samantha Everitt (CMDHB) Observational 13/NTB/123 Approve 178-CL-101.To find out in patients with overactive bladder (OAB) if combinations of two drugs (Solifenacin Succinate and Mirabegron) are safe, well tolerated and have efficacy, compared to placebo and Mr Stephen Mark Canterbury Urology Research Points Research Ltd,John Tuckey,michael holmes,Patrick James Meffan,Tauranga Urology Research Ltd Intervention 13/NTB/124 Approve Type 2 diabetes in dialysis patients Dr Jasmine Tan Clinical A/Prof John Collins,Professor Tim Cundy Auckland District Health Board Observational 13/NTB/125 Approve MDMA and tinnitus Dr Grant Searchfield Intervention 13/NTB/126 Approve OPTIMIST A Prof Peter Dargaville Dr Mariam Buksh Intervention 13/NTB/128 Decline Metacognitive Therapy for Anorexia Nervosa Associate Professor Janet Carter Intervention 13/NTB/129 Approve An investigation into the tolerability of Manuka CyclopowerTM chewable tablets Dr Chepulis Intervention 13/NTB/130 Approve Evaluation of TAF vs TDF in patients with HBeAg positive Chronic HBV Prof Edward Gane Auckland Clinical Studies Limited,Christopher Moyes Intervention 13/NTB/131 Approve Evaluation of TAF vs TDF in patients with negative Chronic HBV Prof Edward Gane Auckland Clinical Studies Limited,Christopher David Moyes Intervention 13/NTB/143 Approve Effectiveness and Safety of FG-4592 for the treatment of anaemia in people with CKD not on dialysis Dr David M. Voss Dr Kannaiyan Rabindranath Dr Samantha Everitt (CMDHB),Jan Adams, COO Intervention 13/NTB/144 Provisionally approve Aspiration therapy for treating obesity Dr Dinesh Lal Intervention Trial
northern-b-ethics-committee-annual-report-2013.docx